NL-based DSM to merge with Firmenich in shares and cash deal

Date: 2022-06-01   Author: Pankaj Singh  Category: #news

NL-based DSM to merge with Firmenich in shares and cash deal

Dutch multinational corporation DSM N.V. has reportedly planned to merge with Firmenich, the world’s largest perfumery and taste company in a mega cash and share deal.

The merger is expected to augment annual sales by USD 537 million, particularly by consolidating Firmenich’s Taste & Beyond and DSM’s Food & Beverage businesses.

Initially, DSM stakeholders will own around 65.5% of the merged entity, and the Firmenich stakeholders will own around 34.5% of the merged company, receiving USD 3.8 billion in cash.

The merger is anticipated to be executed in the first half of next year, and the newly merged company will be listed on Euronext Amsterdam and domiciled in Switzerland.

DSM-Firmenich will possess integrated capabilities across taste, fragrance, nutrition, and texture, boosted by high-quality science.

Both parties stated that this merger will be between two companies with a thriving track record and a common objective to have a positive impact on the people as well as the planet.

Thomas Leysen, Chairman of the DSM Supervisory Board mentioned that the DSM-Firmenich merger will introduce advanced science, innovation, and leading creativity.

The merger will bring together close to 28,000 people. The global Perfumery and Ingredients business of Firmenich will further expand into Beauty with the inclusion of the Personal Care & Aroma business of DSM.

The merged entity also intends to form a new global-scale partner to cater to the F&B industry, consolidating Firmenich’s Taste & Beyond and DSM’s Food & Beverage businesses.

The new consolidated businesses will be joined by DSM’s Nutrition & Care, Health, and Animal Nutrition & Health businesses.

The merger will introduce an alluring yearly run rate synergy of USD 375 million adjusted with EBITDA with an expected mid-term sustainable organic sales growth of 5% to 7% driven by innovation. Both companies expect a 22-23% mid-term adjusted EBITDA margin backed by synergies.

Source credit:

https://www.foodingredientsfirst.com/news/dsm-firmenich-us38b-merger-of-two-iconic-companies-to-unify-science-and-innovation.html



About Author


Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Cardiac Resynchronization Therapy (CRT) Devices Market to 2026 - Growth Trends and Revenue Statistics

Author: Rahul Varpe

A highly analytical qualitative as well as quantitative evaluation of the Cardiac Resynchronization Therapy (CRT) Devices Market has been covered in this report. The study evaluates the myriad aspects of this industry by taking into consideration ...


Medical Products Market Growth Rate, Revenue and Demand Analysis to 2026

Author: Rahul Varpe

An extremely definite evaluation of the Medical Products Market in terms of qualitative as well as quantitative analysis has been covered in this report. The myriad aspects of this industry, having considered its historical and forecast data have ...


Intensive Care Beds Market - Geography Insights and Opportunity Analysis to 2026

Author: Rahul Varpe

The latest study provides an in-depth analysis of the Intensive Care Beds Market focusing on various market definitions, segmentations, sub-segmentations, products, as well as applications. The report further details of the competitive landscape &...